Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet medical ...
Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the lower limit of detection (LLOD), is associated with better clinical outcomes of ...
Fifteen years ago, doctors in Europe noticed a remarkable thing happening in people with chronic hepatitis B infections. When patients went off their medications, the virus started to come back—and ...
Liver specialist Maurizio Bonacini is in the race for a cure for hepatitis B, one of the world’s most widespread diseases and a top cause of liver cancer around the globe. “It’s the last frontier,” ...
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) recently presented compelling data on its investigational hepatitis B therapies, imdusiran and AB-101, at the European Association for the ...
Jody Baron and Gabi Fragiadakis discover why some people with chronic Hepatitis B are cured after they're taken off of ...
ST. LOUIS – Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and resurfacing even after treatment. But, thanks to a new class of ...
NEWTON, Mass., October 15, 2025--(BUSINESS WIRE)--ClearB Therapeutics, Inc., a clinical-stage biotechnology company committed to developing therapies to drive functional cure in patients with chronic ...
A large percentage of US patients eligible for HBV treatment remain untreated, despite effective therapies reducing adverse outcomes like cirrhosis and hepatocellular carcinoma. Disparities in HBV ...
St. Louis -- In a pair of articles published in Lancet Gastroenterology and Hepatology, scientists lay out the case for why we should expand treatment recommendations for people with hepatitis B.
In conjunction with World Hepatitis Day, observed annually on July 28, the Ministry of Health announced significant progress ...